Pioglitazone utilization, efficacy & safety in Indian type 2 diabetic patients: A systematic review & comparison with European Medicines Agency Assessment Report (Q33568852)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Pioglitazone utilization, efficacy & safety in Indian type 2 diabetic patients: A systematic review & comparison with European Medicines Agency Assessment Report |
scientific article |
Statements
1 reference
7 references
13 March 2019
14 March 2019
Pioglitazone utilization, efficacy & safety in Indian type 2 diabetic patients: A systematic review & comparison with European Medicines Agency Assessment Report (English)
1 reference
Sarayu A Pai
1 reference
Nilima A Kshirsagar
1 reference
1 November 2016
8 references
13 March 2019
14 March 2019
24 March 2019
2 August 2019
17 September 2019
23 November 2020
4 February 2021
8 references
13 March 2019
14 March 2019
24 March 2019
2 August 2019
17 September 2019
23 November 2020
4 February 2021
7 references
13 March 2019
14 March 2019
24 March 2019
2 August 2019
17 September 2019
23 November 2020
4 February 2021
1 reference
1 reference
1 reference
Identifiers
1 reference